A detailed history of Axs Investments LLC transactions in Pfizer Inc stock. As of the latest transaction made, Axs Investments LLC holds 98,602 shares of PFE stock, worth $2.62 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
98,602
Holding current value
$2.62 Million
% of portfolio
0.81%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $2.73 Million - $3.1 Million
98,602 New
98,602 $2.85 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $919,148 - $1.19 Million
-35,176 Reduced 93.55%
2,426 $69,000
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $117,064 - $136,836
3,648 Added 10.74%
37,602 $1.25 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $72,817 - $84,248
2,016 Added 6.31%
33,954 $1.25 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $233,937 - $304,551
5,939 Added 22.84%
31,938 $1.3 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $17,075 - $22,290
-409 Reduced 1.55%
25,999 $1.33 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $54,087 - $66,027
1,236 Added 4.91%
26,408 $1.16 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $815,810 - $967,295
17,533 Added 229.52%
25,172 $1.32 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $234,926 - $291,103
-5,135 Reduced 40.2%
7,639 $395,000
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $527,821 - $782,407
12,774 New
12,774 $754,000
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $869,701 - $1.12 Million
-22,158 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $56,450 - $63,948
1,572 Added 7.64%
22,158 $868,000
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $689,425 - $777,533
20,586 New
20,586 $746,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Axs Investments LLC Portfolio

Follow Axs Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axs Investments LLC with notifications on news.